Plunkett Research Online: Cotinga Pharmaceuticals

COTINGA PHARMACEUTICALS (COTQF) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel ora.....


COTINGA PHARMACEUTICALS

Ticker: COTQF
Exchange: PINX
Parent Company:
Employees:
Fiscal Year Ends in

Phone: 519 858-5157
Fax: 519 858-5179
Address: 100 Collip Circle
London, ON N6G 4X8 Canada

Map
Types Of Business
Industry Ranks

Industry NAICS code:

Contacts Description

Alison SilvaCEO/Director/President
Victor HugoCFO
See More
Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel ora.....See More See More

$USD, In whole numbers2023202220212020201920182017
Sales
Profits
Brands, Divisions and Affiliates Top Salaries
Salary
Bonus
Other Thoughts Corporate Culture